Paid

Advances in diabetes technology and treatment over the past decade have failed to yield desired glycemic outcomes in many patients with T2DM.

Numerous complications associated with diabetes, including the risk of death, begin at the pre-diabetic stage.

The FDA has given a Fast Track Designation to accelerate study of Farxiga’s effect on reduction in mortality and heart failure after a heart attack.

Lyumjev, recently approved by the FDA, reaches the bloodstream only one minute after injection; how does its performance compare to Humalog?

Intermittent fasting may help reduce body fat, but how safe is it in a patient with type 2 diabetes?

Analysis of the PIONEER 8 trial reveals dose-dependent reductions in A1c and body weight when oral semaglutide is paired with various insulin regimens.

Thousands of dietary supplements are available for diabetes treatment, but an examination of available studies found that only three ingredients had consistent evidence to support their claims.

A recent study suggests strengthening cancer screening recommendations may be beneficial in patients with T2DM.

Patients with obstructive sleep apnea are at higher risk for developing type 2 diabetes, and the proper treatment may lower the risk. 

Study examines the effectiveness of nutritional ketosis in reducing medication usage and increasing the chances of diabetes remission.